MALAT1 and diabetic kidney disease: Taken together, LncRNA MALAT1/miR-30c, LncRNA NEAT2/miR-206 and Circ_0004951/miR-93-5p are all expected to be potential targets for clinical targeting of RTEC pyroptosis to treat DKD.